All ProductsDisplaying Products by Catalog Number (1400 - 1499)
01000200030004000500060007000800090010001100120013001400150016001700180019002000210022002300240025002600270028002900300031003200330034003500360037003800390040004100420043004400450046004700480049005000510052005300540055005600570058005900600061006200630064006500660067006800690070007100720073007400750076007700780079008000810082008300840085008600870088008900
| Cat. No. | Product Name / Activity |
|---|---|
| 1400 | SCH 202676 hydrobromide |
| Inhibitor of ligand binding to G-protein-coupled receptors | |
| 1402 | SB 203580 hydrochloride |
| Selective inhibitor of p38 MAPK; water-soluble | |
| 1403 | FPL 64176 |
| Potent CaV1.x activator | |
| 1406 | Trichostatin A |
| Potent histone deacetylase inhibitor | |
| 1407 | PP 2 |
| Potent, selective Src family kinase inhibitor | |
| 1408 | YM 022 |
| Highly potent, selective non-peptide CCK2 antagonist | |
| 1412 | Chromanol 293B |
| IKs blocker. Also blocks ICFTR | |
| 1414 | Scopolamine hydrobromide |
| Non-selective muscarinic antagonist | |
| 1415 | 1400W dihydrochloride |
| Potent, highly selective iNOS inhibitor | |
| 1416 | Homoharringtonine |
| Inhibitor of protein synthesis; antileukemic agent | |
| 1418 | Resveratrol |
| Cyclooxygenase inhibitor | |
| 1422 | DCEBIO |
| Activates Cl- conductance and hKCa3.1 channels | |
| 1425 | (S)-(+)-Dimethindene maleate |
| Selective M2 antagonist | |
| 1426 | PPT |
| Subtype-selective ERα agonist | |
| 1427 | Citalopram hydrobromide |
| Highly potent and selective 5-HT uptake inhibitor | |
| 1428 | Amyloid β-Peptide (1-42) (human) |
| Predominant amyloid β-protein fragment | |
| 1431 | DPDPE |
| Selective δ agonist | |
| 1435 | SQ 22536 |
| Adenylyl cyclase inhibitor | |
| 1437 | D609 |
| Selective PC-PLC inhibitor | |
| 1439 | Ruthenium Red |
| Non-selective CaV2.1 and 2.2 blocker; also blocks TRPV channels | |
| 1443 | Metastin (human) |
| Potent, endogenous ligand for kisspeptin receptor | |
| 1447 | SKF 81297 hydrobromide |
| D1 agonist | |
| 1448 | Formoterol hemifumarate |
| Potent and selective β2 agonist | |
| 1453 | Clemastine fumarate |
| H1 antagonist | |
| 1454 | GYKI 52466 dihydrochloride |
| Selective non-competitive AMPA antagonist | |
| 1455 | Orexin A (human, rat, mouse) |
| Endogenous agonist at OX1 and OX2 | |
| 1456 | Orexin B (human) |
| Endogenous agonist at OX1 and OX2 | |
| 1457 | Orexin B (mouse) |
| Endogenous agonist at OX1 and OX2 | |
| 1462 | AACOCF3 |
| Phospholipase A2 inhibitor | |
| 1463 | Ghrelin (human) |
| Endogenous ghrelin receptor agonist | |
| 1464 | TFLLR-NH2 |
| PAR1-activating peptide | |
| 1465 | Ghrelin (rat) |
| Endogenous ghrelin receptor agonist | |
| 1467 | Daunorubicin hydrochloride |
| DNA topoisomerase II inhibitor | |
| 1468 | SLIGRL-NH2 |
| PAR2-activating peptide | |
| 1469 | CGP 37849 |
| Potent and selective NMDA antagonist | |
| 1470 | Flecainide acetate |
| Cardiac Na+ channel blocker. Antiarrhythmic | |
| 1471 | Etomidate |
| GABA-mimetic; selectively interacts with β2- and β3-subunit containing GABAA receptors | |
| 1472 | Suramin hexasodium salt |
| Non-selective P2 antagonist | |
| 1475 | (-)-[3R,4S]-Chromanol 293B |
| IKs blocker. Enantiomer of Chromanol 293B (Cat. No. 1412) | |
| 1476 | Gap 27 |
| Selective gap junction blocker | |
| 1477 | GR 127935 hydrochloride |
| Potent and selective 5-HT1B and 5-HT1D antagonist | |
| 1478 | Proglumide sodium salt |
| Non-selective CCK antagonist; orally active | |
| 1479 | Mifepristone |
| Progesterone and glucocorticoid receptor antagonist | |
| 1482 | D-myo-Inositol 1,4,5-trisphosphate, hexapotassium salt |
| Ca2+ mobilizing second messenger | |
| 1483 | GR 89696 fumarate |
| Subtype-selective κ agonist | |
| 1484 | Oleylethanolamide |
| Lipid mediator, anorexic actions; also GPR55 and PPARα agonist | |
| 1487 | AY-NH2 |
| Selective PAR4 agonist | |
| 1489 | Mithramycin A |
| Inhibitor of DNA and RNA polymerase | |
| 1490 | MNI-caged-L-glutamate |
| Stable photoreleaser of L-glutamate | |
| 1493 | CGP 78608 hydrochloride |
| Potent and selective NMDA antagonist; acts at glycine site | |
| 1494 | DPN |
| Highly potent ERβ agonist | |
| 1496 | SP 600125 |
| Selective JNK inhibitor | |
| 1497 | Rimcazole dihydrochloride |
| σ2 antagonist. Also DAT inhibitor | |
| 1499 | CL 316243 disodium salt |
| Highly selective β3 agonist |